Hepatitis E during Tocilizumab Therapy in a Patient with Rheumatoid Arthritis: Case Report and Literature Review
Hepatitis E is an acute self-limiting disease caused by hepatitis E virus (HEV). Recent reports show that HEV can induce chronic hepatitis or be reactivated in immunocompromised hosts. We report a 63-year-old woman with rheumatoid arthritis (RA) who developed hepatitis E during treatment with tocili...
Saved in:
| Main Authors: | Hidekazu Ikeuchi, Kana Koinuma, Masao Nakasatomi, Toru Sakairi, Yoriaki Kaneko, Akito Maeshima, Yuichi Yamazaki, Hiroaki Okamoto, Toshihide Mimura, Satoshi Mochida, Yoshihisa Nojima, Keiju Hiromura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Case Reports in Rheumatology |
| Online Access: | http://dx.doi.org/10.1155/2018/6873276 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diverse Cell Populations Involved in Regeneration of Renal Tubular Epithelium following Acute Kidney Injury
by: Akito Maeshima, et al.
Published: (2015-01-01) -
Successful maintenance therapy with tocilizumab for severe acute liver failure associated with adult-onset still’s disease
by: Koji Suzuki, et al.
Published: (2025-01-01) -
RAPID EFFECT OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS
by: E Yu Panasyuk, et al.
Published: (2011-08-01) -
PROSPECTS FOR USING TOCILIZUMAB IN SYSTEMIC SCLEROSIS
by: L. P. Ananyeva
Published: (2016-02-01) -
Tocilizumab for the Treatment of Mevalonate Kinase Deficiency
by: Nadia K. Rafiq, et al.
Published: (2018-01-01)